Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Mapping the Enhanced Landscape of Advanced Breast Cancer fOr DYnamic Treatment Approaches (MELODY)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07893730
Title field or adapter rule
{'original_value': 'Mapping the Enhanced Landscape of Advanced Breast Cancer fOr DYnamic Treatment Approaches (MELODY)', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:30.200285+00:00
Published At
2026-10-26T00:00:00+00:00
Record Updated At
2026-10-26
Source Retrieved At
2026-10-31T22:18:19.086215+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Breast Cancer", "Metastatic Breast Cancer", "Locally Advanced Breast Cancer (LABC)"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-26", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07893730"
protocolSection.identificationModule.officialTitle
"Mapping the Enhanced Landscape of Advanced Breast Cancer fOr DYnamic Treatment Approaches (MELODY)"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Breast Cancer (protocolSection.conditionsModule.conditions)
  • Metastatic Breast Cancer (protocolSection.conditionsModule.conditions)
  • Locally Advanced Breast Cancer (LABC) (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Liquid Biopsy Genomic Profiling'], 'description': 'Blood-based genomic profiling of circulating tumour nucleic acids, performed at baseline and serially, to identify genomic alterations and inform comparison with tumour-tissue sequencing and potential treatment actionability.', 'name': 'Liquid biopsy next generation sequencing', 'type': 'DIAGNOSTIC_TEST'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.